{{Rsnum
|rsid=10510468
|Gene=PLCL2
|Chromosome=3
|position=16897125
|Orientation=plus
|GMAF=0.06749
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=PLCL2
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 93.8 | 6.2 | 0.0
| HCB | 94.2 | 5.8 | 0.0
| JPT | 96.5 | 3.5 | 0.0
| YRI | 61.9 | 36.7 | 1.4
| ASW | 75.0 | 23.2 | 1.8
| CHB | 94.2 | 5.8 | 0.0
| CHD | 97.2 | 2.8 | 0.0
| GIH | 88.0 | 11.0 | 1.0
| LWK | 68.2 | 30.9 | 0.9
| MEX | 79.3 | 20.7 | 0.0
| MKK | 79.5 | 19.2 | 1.3
| TSI | 93.1 | 6.9 | 0.0
| HapMapRevision=28
}}SNP [[rs10510468]] has been associated with both very-low density lipoprotein levels and high-density lipoprotein levels in the Framingham Heart Study datasets, and is thus associated with [[heart disease]]. [http://gmed.bu.edu/about/analysis.html source]

{{PMID Auto
|PMID=17903299
|Title=A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study.
|OA=1
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}